Summary
We estimated the concentration of soluble IL-2R (sIL-2R) in the serum of patients with systemic lupus erythematosus (SLE) and examined the relationship between the serum levels of sIL-2R and clinical features or laboratory data. We found that elevated levels of sIL-2R were present in the serum of SLE patients with discoid rash, and sIL-2R concentrations were correlated with the soluble CD4 and soluble CD8 concentrations but not with classical serological marker, anti-DNA antibody or complement titer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Talal, N. Disordered immunologic regulation and autoimmunity. Transplant Rev 1976, 31, 240.
Smith, H.R., Steinberg, A.D. Autoimmunity: A perspective. Ann Rev Immunol 1983, 1, 175.
Fauci, A.S., Steinberg, A.D., Haynes, B.F., Whalen, G. Immunoregulatory aberrations in systemic lupus erythematosus. J Immunol 1978, 121, 1473.
Morimoto, C., Steinberg, A.D., Letvin, N.L., Hagan, M., Takeuchi, T., Daley, J., Levine, H., Schlossman, S.F. A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest 1987, 79, 762.
Tsokos, G.C., Balow, J.E. Spontaneous and pokeweed mitogen-induced plaque-forming cells in systemic lupus erythematosus. Clin Immunol Immunopathol 1981, 21, 172.
Lockshin, M.D., Eisenhauer, A.C., Kohn, R., Weksler, M., Block, S., Mushlin, S.B. Mitogen responses in RA, SLE and other illnesses: Correlation with T- and B-lymphocyte populations. Arthritis Rheum 1975, 18, 245.
Linker-Israeli, M. Bakk, A.C., Kitridou, R.C., Gendle, S., Gillis, S., Horowitz, D.A. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol 1983, 130, 2651.
Yu, D.T.Y., Winchester, R.J., Fu, S.M., Gibofsky, A., Ko, H.S. Kunkel, H.G. Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization. J Exp Med 1980, 151, 91.
Smith, K.A. T cell growth factor. Immunol Rev 1980, 51, 337.
Tsudo, M., Uchiyama, T., Uchino, H., Yodoi, J. Failure of regulation of Tac antigen /TCGF receptor on adult T-cell leukemia cells by anti-Tac monoclonal antibody. Blood 1983, 61, 1014.
Ko, H.S., Fu, S.M., Winchester, R.J. Yu, D.T.Y., Kunkel, H.G. Ia determinants on stimulated human T lymphocytes: Occurrence on mitogen- and antigen-activated T cells. J Exp Med 1979, 150, 246.
Trowbridge, I.S., Omary, M.B. Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci USA 1981, 78, 3039.
Rubin, L.A., Kurman, C.C., Fritz, M.E., Biddison, W.E., Boutin, B., Yarchoan, R., Nelson, D.L. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985, 135, 3172.
Mackeen, L., Brown, M., Ip, S.H., Kung, P.C., Yasuda, N., Harrington, D., Hinuma, Y., Weisenburger, D., Lay, P., Purtilo, D. Serum interleukin-2 receptor as a marker for active T cell malignancies. Fed Proc 1986, 45, 454.
Nelsone, D.L. Soluble interleukin-2 receptor: Analysis in normal individuals and in certain disease stages. Fed Proc 1986, 45, 377.
Wolf, R.E., Brelsford, W.G. Soluble interleukin-2 receptors in systemic lupus erythematosus. Arthritis Rheum 1988, 31, 729.
Reske-Kunz, A.B., Osawa, H., Josimovic-Alasevico, O., Rude, E., Diamanstain, T. Soluble interleukin 2 receptors are released by long term cultured insulin-specific T cells transiently after contact with antigen. J Immunol 1985, 138, 192.
Sawada, S., Iijima, S., Hashimoto, H., Tokano, Y., Takei, M., Shida, M., Obara, T. Increased soluble CD8, CD4 molecules in patients with systemic lupus erythematosus. J Clin Lab Analysis, in press.
Griffin, D.E., Ward, B.J., Jauregui, E., Johnson, R.T., Vaisberg, A. Immune activation in measles. 1989, 320, 1667.
Tomkinson, B.E., Brown, M.C., Ip, S.H., Carrabis, S., Sullivan, J.L. Soluble CD8 during T cell activation. J Immunol 1989, 142, 2230.
Agostini, C., Semenzato, G., Vinante, F., Sinicco, A., Trentin, L., Zambello, R., Zuppini, B., Zanotti, R., Siviero, F., Veneri, D. Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS related disorders. Clin Immunol Immunopathol 1989, 50, 146.
Bautin, B., Matsuguchi, L., Lebon, P., Ponst, G., Arthus, M., Nelson, D. Soluble IL-2 receptors in acute and subacute encephalitis. Ann Neurol 1987, 22, 659.
Obara, T., Vodian, M.A., Kung, P.C. Clinical significance of soluble interleukin 2 receptor for monitoring the disease associated with active lymphocytes and viral infections. J Clin Lab Analysis 1992, 6, 91.
Tendler, C.L., Greenberg, S.J., Blattner, W.A., Manns, A., Murphy, E., Fleisher, T., Hanchard, B., Morgan, O., Burton, J.D., Nelson, D.L. Transactivation of interleukin 2 and its receptor induces immune activation in human T cell lymphtropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc Natl Acad Sci USA 1990, 87, 5218.
Honda, M., Kitamura, K., Kasuda, K., Yokota, Y., Yamamoto, N., Mistuyasu, R., Chermann, J.C., Tokunaga, T. Soluble IL-2 receptor in AIDS: Correlation of its serum level with the classification of HIV induced diseases and its characterization. J Immunol 1989, 142, 4248.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sawada, S., Hashimoto, H., Iijma, S. et al. Increased soluble IL-2 receptor in serum of patients with systemic lupus erythematosus. Clin Rheumatol 12, 204–209 (1993). https://doi.org/10.1007/BF02231527
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02231527